PA8637801A1 - Metabolitos de indolilalquilamina como ligandos de 5-hidroxitriptamina-6 - Google Patents
Metabolitos de indolilalquilamina como ligandos de 5-hidroxitriptamina-6Info
- Publication number
- PA8637801A1 PA8637801A1 PA20058637801A PA8637801A PA8637801A1 PA 8637801 A1 PA8637801 A1 PA 8637801A1 PA 20058637801 A PA20058637801 A PA 20058637801A PA 8637801 A PA8637801 A PA 8637801A PA 8637801 A1 PA8637801 A1 PA 8637801A1
- Authority
- PA
- Panama
- Prior art keywords
- indolilalkylamine
- hydroxythyriptamine
- metabolites
- ligands
- receiver
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title 1
- 239000002207 metabolite Substances 0.000 title 1
- 239000002131 composite material Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/02—Acyclic radicals
- C07H7/033—Uronic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
LA PRESENTE INVENCION PROPORCIONA UN COMPUESTO DE FORMULA I Y SU USO PARA EL TRATAMIENTO TERAPEUTICO DE TRASTORNOS RELACIONADOS CON EL RECEPTOR 5-HT6 O AFECTADOS POR DICHO RECEPTOR.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58229004P | 2004-06-23 | 2004-06-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8637801A1 true PA8637801A1 (es) | 2006-06-02 |
Family
ID=35033547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20058637801A PA8637801A1 (es) | 2004-06-23 | 2005-06-23 | Metabolitos de indolilalquilamina como ligandos de 5-hidroxitriptamina-6 |
Country Status (19)
Country | Link |
---|---|
US (1) | US7498327B2 (es) |
EP (1) | EP1758898A1 (es) |
JP (1) | JP2008504267A (es) |
KR (1) | KR20070041514A (es) |
CN (1) | CN1976928A (es) |
AR (1) | AR049449A1 (es) |
AU (1) | AU2005258025A1 (es) |
BR (1) | BRPI0512540A (es) |
CA (1) | CA2570818A1 (es) |
CR (1) | CR8825A (es) |
EC (1) | ECSP067096A (es) |
IL (1) | IL180198A0 (es) |
MX (1) | MX2007000182A (es) |
NO (1) | NO20070065L (es) |
PA (1) | PA8637801A1 (es) |
PE (1) | PE20060303A1 (es) |
RU (1) | RU2006146923A (es) |
TW (1) | TW200606148A (es) |
WO (1) | WO2006002125A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7635710B2 (en) | 2006-02-15 | 2009-12-22 | Neurim Pharmaceuticals (1991) Ltd. | Pyrone-indole derivatives and process for their preparation |
US9101613B2 (en) | 2006-02-15 | 2015-08-11 | Neurim Pharmaceuticals (1991) Ltd. | Methods for treating neurological disease |
EP1953153A1 (en) * | 2007-01-31 | 2008-08-06 | Laboratorios del Dr. Esteve S.A. | Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
EP2053052A1 (en) | 2007-10-23 | 2009-04-29 | Laboratorios del Dr. Esteve S.A. | Process for the preparation of 6-substituted imidazo[2,1-b]thiazole-5-sulfonyl halide |
WO2015090233A1 (en) | 2013-12-20 | 2015-06-25 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic compounds and their application in pharmaceuticals |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3489767A (en) * | 1966-01-12 | 1970-01-13 | Sumitomo Chemical Co | 1-(phenylsulfonyl)-3-indolyl aliphatic acid derivatives |
GB9820113D0 (en) * | 1998-09-15 | 1998-11-11 | Merck Sharp & Dohme | Therapeutic agents |
US6380166B1 (en) * | 1999-09-13 | 2002-04-30 | American Home Products Corporation | Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols |
CA2470863C (en) * | 2001-12-20 | 2012-05-15 | Wyeth | Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
JPWO2004078719A1 (ja) * | 2003-03-06 | 2006-06-08 | 小野薬品工業株式会社 | インドール誘導体化合物およびその化合物を有効成分とする薬剤 |
RU2356889C2 (ru) * | 2003-07-17 | 2009-05-27 | Плекссикон, Инк. | Соединения, являющиеся активными по отношению к рецепторам, активируемым пролифератором пероксисом |
WO2005040112A1 (en) * | 2003-10-14 | 2005-05-06 | Oxagen Limited | Compounds with pgd2 antagonist activity |
-
2005
- 2005-06-17 PE PE2005000696A patent/PE20060303A1/es not_active Application Discontinuation
- 2005-06-21 WO PCT/US2005/021852 patent/WO2006002125A1/en active Application Filing
- 2005-06-21 BR BRPI0512540-5A patent/BRPI0512540A/pt not_active IP Right Cessation
- 2005-06-21 KR KR1020077000822A patent/KR20070041514A/ko not_active Application Discontinuation
- 2005-06-21 CN CNA2005800206836A patent/CN1976928A/zh active Pending
- 2005-06-21 RU RU2006146923/04A patent/RU2006146923A/ru not_active Application Discontinuation
- 2005-06-21 TW TW094120536A patent/TW200606148A/zh unknown
- 2005-06-21 CA CA002570818A patent/CA2570818A1/en not_active Abandoned
- 2005-06-21 AU AU2005258025A patent/AU2005258025A1/en not_active Abandoned
- 2005-06-21 AR ARP050102544A patent/AR049449A1/es unknown
- 2005-06-21 JP JP2007518190A patent/JP2008504267A/ja not_active Withdrawn
- 2005-06-21 EP EP05766100A patent/EP1758898A1/en not_active Withdrawn
- 2005-06-21 MX MX2007000182A patent/MX2007000182A/es active IP Right Grant
- 2005-06-22 US US11/158,702 patent/US7498327B2/en not_active Expired - Fee Related
- 2005-06-23 PA PA20058637801A patent/PA8637801A1/es unknown
-
2006
- 2006-12-19 IL IL180198A patent/IL180198A0/en unknown
- 2006-12-19 EC EC2006007096A patent/ECSP067096A/es unknown
- 2006-12-21 CR CR8825A patent/CR8825A/es not_active Application Discontinuation
-
2007
- 2007-01-04 NO NO20070065A patent/NO20070065L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2006146923A (ru) | 2008-07-27 |
BRPI0512540A (pt) | 2008-03-25 |
US7498327B2 (en) | 2009-03-03 |
US20060003945A1 (en) | 2006-01-05 |
WO2006002125A1 (en) | 2006-01-05 |
IL180198A0 (en) | 2007-06-03 |
CR8825A (es) | 2007-08-28 |
CA2570818A1 (en) | 2006-01-05 |
CN1976928A (zh) | 2007-06-06 |
MX2007000182A (es) | 2007-03-23 |
JP2008504267A (ja) | 2008-02-14 |
ECSP067096A (es) | 2007-02-28 |
AU2005258025A1 (en) | 2006-01-05 |
EP1758898A1 (en) | 2007-03-07 |
TW200606148A (en) | 2006-02-16 |
AR049449A1 (es) | 2006-08-02 |
KR20070041514A (ko) | 2007-04-18 |
PE20060303A1 (es) | 2006-05-19 |
NO20070065L (no) | 2007-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP055964A (es) | Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6 | |
CR7643A (es) | Derivados de 1-heterociclialquil -3-sulfonilazaindol o azaindazol como ligandos de 5-hidroxitriptamina-6 | |
ECSP034810A (es) | Derivados heterociclilalcoxi-, -alquiltio- y - alquilaminobenzazol tales como ligandos 5-hidroxitriptamina-6 | |
UY30572A1 (es) | N-(1-ftalazin-1-il-piperidin-4-il)-amidas como moduladores del receptor ep2 | |
ECSP055536A (es) | Derivados de 1-heterociclilalquil-3-sulfonilindol o indazol como ligandos de 5-hidroxitriptamina-6 | |
DOP2005000025A (es) | Compuestos de heteroaril- y fenilsulfamoilo sustituidos | |
PA8770101A1 (es) | Amidas de 4-aril-1,4-dihidro-1, 6-naftiridina sustituidas y su uso | |
CR9034A (es) | Preparacion y uso de derivados de acido bifenil-4-il-carbonilamino para el tratamiento de la obesidad | |
UY28752A1 (es) | Agentes terapeuticos | |
EA200900202A1 (ru) | Селективные модуляторы андрогенного рецептора, их аналоги и производные и их использование | |
CL2007001885A1 (es) | Compuestos derivados de urea de tropano, moduladores de la actividad de la 11betahsd1; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento de enfermedades tales como obesidad, diabetes, hipertension, aterosclerosis, demencia y osteoporosis. | |
ATE441646T1 (de) | 5-ht4-rezeptoragonistenverbindungen | |
ATE431824T1 (de) | Chinolinon-carboxamid-verbindungen | |
ECSP045156A (es) | Derivados de indolilalquilamina como ligandos 5-hidroxitriptamina-6 | |
UY28839A1 (es) | Agentes terapeuticos | |
CL2011000544A1 (es) | Compuestos derivados de benzamida n sustituida por heterociclo, ligandos de los receptores cannabinoides; composicion farmaceutica; y su uso para tratar el dolor, entre otras enfermedades. | |
BRPI0614397A2 (pt) | compostos de pirimidina como moduladores de receptor de serotonina | |
CL2007002384A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis. | |
PA8795601A1 (es) | Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de histamina-3 | |
ECSP099675A (es) | Compuestos heterocíclicos, composición y métodos de uso | |
ECSP088366A (es) | 1,2-diarilimidazoles para uso como moduladores de cb1 | |
ECSP11010867A (es) | Compuestos novedosos de fenilamino-isonicotinamida | |
HN2003000080A (es) | Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso | |
CR9733A (es) | Derivados de azinil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6 | |
PA8637801A1 (es) | Metabolitos de indolilalquilamina como ligandos de 5-hidroxitriptamina-6 |